Revvity | PKI - 现金及等价物



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 15.86B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


现金及等价物 更改 日
Agilent USD 1.76B 49M 2026-06
Align Technology USD 1.1B 42.76M 2026-06
Bio Techne USD 264.71M 54.89M 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Charles River Laboratories USD 192.02M 195K 2026-06
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Edwards Lifesciences USD 2.9B 500M 2026-06
Illumina USD 1.09B 329M 2026-03
Intuitive Surgical USD 8.63B 646.3M 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Laboratory Of America USD 141.8M 839.3M 2026-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
OraSure Technologies USD 160.58M 16.38M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Quest Diagnostics USD 626M 233M 2026-06
Quidel USD 123.4M 17M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tilray USD 264.83M 43.16M 2025-06
Waters USD 539M 77M 2026-06
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03